View all cases
UPC APP 3214/2025
Jan 21, 2025·EP3666797: ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)
- Case details
- StatusWritten PhaseActionGenericCategoryOther Procedural
- Parties
- Respondents
- Sanofi-Aventis Deutschland GmbH
- Amgen Inc.
- Dehns
- Name not displayed for GDPR reasons. Represented by Oswin RIDDERBUSCH
Reps: Daniel Wise; Koen Bijvank; John Somerton; Oswin Ridderbusch - Division
- Munich CD
- Technology
- Biotechnology
- Language
- English
Documents
| Document title | Date | Public |
|---|---|---|
| preliminary order re representation | 2025-02-18 | Not public |
| US Delaware District Court Memorandum Order | 2025-02-11 | Not public |
| 2025.02.11 Response to Rule 262.1(b) RoP - signed | 2025-02-11 | Not public |
| 2025.02.11 Response to Rule 262.1(b) RoP - signed | 2025-02-11 | Not public |
| US Delaware District Court Memorandum Order | 2025-02-11 | Not public |
| 2025.02.11 Response to Rule 262.1(b) RoP - signed | 2025-02-11 | Not public |
| US Delaware District Court Memorandum Order | 2025-02-11 | Not public |
| Reply to Rule 262.1 (b) | 2025-02-11 | Not public |
| PO consulting parties | 2025-01-28 | Not public |
| Application for access to files RoP art. 262 b) | 2025-01-21 | Not public |